Key Statistics
Market Cap$1.94B
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.74
52W High$21.50
52W Low$9.61
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees—
Price Performance
1 Week+3.06%
3 Month-19.03%
1 Year+40.11%
About
Mesoblast Limited, a biopharmaceutical company, develops and markets allogeneic cellular drugs. The company is headquartered in Melbourne, Australia.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze MESO with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.